RS1333042 CDKN2B-AS1

Protective Chr 9:22103813 snv intron variant
Upload your DNA to see your genotype for this variant.
What This Variant Does
"rs1333042 increases susceptibility to Coronary artery disease 1.29 times for heterozygotes (AG) and ..."
Associated Conditions
GWAS Studies (15)
Trait Risk Allele OR / Beta P-value Study
Coronary artery / coronary heart disease (including heart attack, angina) A OR: 0.18 8E-129 PubMed
Takes medication for coronary artery/ coronary heart disease? A OR: 0.17 9E-109 PubMed
Ischemic heart disease (PheCode 411) G 2E-72 PubMed
Medication use for hyperlipidemia (number of purchases) β: 0.017 3E-41 PubMed
Parental longevity (father's age at death) A β: 0.02 7E-15 PubMed
Other chronic ischemic heart disease, unspecified (PheCode 411.8) A OR: 0.16 9E-14 PubMed
Total lipid levels in chylomicrons and extremely large VLDL G β: 0.01 5E-12 PubMed
Triglyceride levels in chylomicrons and extremely large VLDL G β: 0.01 6E-12 PubMed
Concentration of chylomicrons and extremely large VLDL particles G β: 0.01 2E-10 PubMed
Coronary heart disease OR: 1.3 1E-9 PubMed
Endometriosis or asthma (pleiotropy) A β: 0.06 1E-9 PubMed
Asthma and cardiovascular disease 3E-9 PubMed
Parental longevity (both parents in top 10%) A β: 0.011 2E-8 PubMed
Parental longevity (mother's age at death or mother's attained age) G 3E-7 PubMed
Coronary artery disease β: 0.07 6E-6 PubMed
Population Frequencies
1kG AFR
3.4%
1kG ALL
32.1%
1kG AMR
50.3%
1kG EAS
30.5%
1kG EUR
50.2%
1kG SAS
41.2%
Other Variants in CDKN2B-AS1
Ask Dr. Hemsworth about this variant